Disruption of thrombospondin-2 accelerates ischemic fracture healing

Journal of Orthopaedic Research

Volumn 31, Issue 6, 2013, Pages 935-943

  Miedel, Emily ^a   Dishowitz, Michael I ^a   Myers, Marc H ^a   Dopkin, Derek ^a   Yu, Yan Yiu ^b   Miclau, Ted S ^b   Marcucio, Ralph ^b   Ahn, Jaimo ^c   Hankenson, Kurt D ^a,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

bone fracture healing; ischemia; thrombospondin 2

Indexed keywords

THROMBOSPONDIN 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE DENSITY; BONE MASS; BONE REGENERATION; CELL PROLIFERATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FRACTURE HEALING; HISTOLOGY; LASER DOPPLER FLOWMETRY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TIBIA FRACTURE; VASCULARIZATION;

ANIMALS; ANTIGENS, CD36; ANTIGENS, CD47; APOPTOSIS; BONY CALLUS; CARTILAGE; CELL PROLIFERATION; EXTREMITIES; FRACTURE HEALING; ISCHEMIA; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PHYSIOLOGIC; REGIONAL BLOOD FLOW; THROMBOSPONDIN 1; THROMBOSPONDINS;

EID: 84876291906     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.22302     Document Type: Article

References (36)

1. Einhorn T,. 2005. The science of fracture healing. J Orthop Trauma 19: S4-S6.
2. McKibbin B,. 1978. The biology of fracture healing in long bones. J Bone Joint Surg 60: 150-162.
3. Dickson K, Katzman S, Paiement G,. 1995. The importance of the blood supply in the healing of tibial fractures. Contemp Orthop 30: 489-493.
4. Giannoudis P, Kanakaris N, Dimitriou R, et al. 2009. The synergistic effect of autograft and BMP-7 in the treatment of atrophic nonunions. Clin Orthop Relat Res 467: 3239-3248.
5. Brinker M, Bailey D,. 1997. Fracture healing in tibia fractures with an associated vascular injury. J Trauma 42: 11-19.
6. Bornstein P, Armstrong L, Hankenson KD, et al. 2000. Thrombospondin 2, a matricellular protein with diverse functions. Matrix Biol 19: 557-568.
7. Zhang X, Lawler J,. 2007. Thrombospondin-based antiangiogenic therapy. Microvasc Res 74: 90-99.
8. Greenaway J, Lawler J, Moorehead R, et al. 2007. Thrombospondin-1 inhibits VEGF levels in the ovary directly by binding and internalization via the low density lipoprotein receptor-related protein-1 (LRP-1). J Cell Physiol 210: 807-818.
9. Zhang X, Kazerounian S, Duquette M, et al. 2009. Thrombospondin-1 modulates vascular endothelial growth factor activity at the receptor level. FASEB J 23: 3368-3376.
10. Krady M, Zeng J, Yu J, et al. 2008. Thrombospondin-2 modulates extracellular matrix remodeling during physiological angiogenesis. Am J Pathol 173: 879-891.
11. Isenberg J, Ridnour L, Dimitry J, et al. 2006. CD47 is necessary for inhibition of nitric oxide-stimulated vascular cell responses by thrombospondin-1. J Biol Chem 281: 26069-26080.
12. Isenberg J, Annis D, Pendrak M, et al. 2009. Differential interactions of thrombospondin-1, -2, and -4 with CD47 and effects on cGMP signaling and ischemic injury responses. J Biol Chem 284: 1116-1125.
13. Armstrong L, Bjötkblom B, Hankenson K, et al. 2002. Thrombospondin 2 inhibits microvascular endothelial cell proliferation by a caspase-independent mechanism. Mol Biol Cell 13: 1893-1905.
14. Oganesian A, Armstrong L, Migliorini M, et al. 2008. Thrombospondins use the VLDL receptor and a nonapoptotic pathway to inhibit cell division in microvascular endothelial cells. Mol Biol Cell 19: 563-571.
15. Hankenson K, Bornstein P,. 2002. The secreted protein thrombospondin 2 is an autocrine inhibitor of marrow stromal cell proliferation. J Bone Miner Res 17: 415-425.
16. Hankenson K, Bain S, Kyriakides T,. 2000. Increased marrow-derived osteoprogenitor cells and endosteal bone formation in mice lacking thrombospondin 2. J Bone Miner Res 15: 851-862.
17. Kyriakides T, Tam J, Bornstein P,. 1999. Accelerated wound healing in mice with a disruption of the thrombospondin 2 gene. J Invest Dermatol 113: 782-787.
18. Agah A, Kyriakides T, Letrondo N, et al. 2004. Thrombospondin 2 levels are increased in aged mice: consequences for cutaneous wound healing and angiogenesis. Matrix Biol 22: 539-547.
19. Taylor D, Meganck J, Terkhorn S, et al. 2009. Thrombospondin-2 influences the proportion of cartilage and bone during fracture healing. J Bone Miner Res 24: 1043-1054.
20. Kopp H, Hooper A, Broekman M, et al. 2006. Thrombospondins deployed by thrombopoietic cells determine angiogenic switch and extent of revascularization. J Clin Invest 116: 3277-3291.
21. Isenberg J, Romeo M, Abu-Asab M, et al. 2007. Increasing survival of ischemic tissue by targeting CD47. Circ Res 100: 712-720.
22. Maxhimer J, Isenberg J, Romeo M, et al. 2008. Blocking thrombospondin-1-CD47 signaling enhances tissue survival to ischemia in a porcine model. J Surg Res 144: 265.
23. Thakar C, Zahedi K, Revelo M, et al. 2005. Identification of thrombospondin 1 (TSP-1) as a novel mediator of cell injury in kidney ischemia. J Clin Invest 115: 3451-3459.
24. Isenberg J, Maxhimer J, Powers P, et al. 2008. Treatment of liver ischemia-reperfusion injury by limiting thrombospondin-1/CD47 signaling. Surgery 144: 752-761.
25. Kyriakides T, Zhu Y, Smith L, et al. 1998. Mice that lack thrombospondin 2 display connective tissue abnormalities that are associated with disordered collagen fibrillogenesis, an increased vascular density, and a bleeding diathesis. J Cell Biol 140: 419-430.
26. Tang G, Charo D, Wang R, et al. 2004. CCR2-/- knockout mice revascularize normally in response to severe hindlimb ischemia. J Vasc Surg 40: 786-795.
27. Lu C, Miclau T, Hu D, et al. 2007. Ischemia leads to delayed union during fracture healing: a mouse model. J Orthop Res 25: 51-61.
28. Dishowitz M, Terkhorn S, Bostic S, et al. 2012. Notch signaling components are upregulated during both endochondral and intramembranous bone regeneration. J Orthop Res 30: 296-303.
29. Hopf H, Gibson J, Angeles A, et al. 2005. Hyperoxia and angiogenesis. Wound Repair Regen 13: 558-564.
30. Bassett C, Herrmann I,. 1961. Influence of oxygen concentration and mechanical factors on differentiation of connective tissues in vitro. Nature 190: 460-461.
31. Pawelek J,. 1969. Effects of thyroxine and low oxygen tension on chondrogenic expression in cell culture. Dev Biol 19: 52-72.
32. Rajpurohit R, Koch C, Tao Z, et al. 1996. Adaptation of chondrocytes to low oxygen tension: Relationship between hypoxia and cellular metabolism. J Cell Physiol 168: 424-432.
33. Maile L, DeMambro V, Wai C, et al. An essential role for the association of CD47 to SHPS-1 in skeletal remodeling. J Bone Miner Res 26: 2068-2081.
34. Lieu S, Hansen E, Dedini R, et al. Impaired remodeling phase of fracture repair in the absence of matrix metalloproteinase-2. Dis Model Mech 4: 203-211.
35. van Oorschot A, Smits A, Pardali E, et al. 2011. Low oxygen tension positively influences cardiomyocyte progenitor cell function. J Cell Mol Med 15: 2723-2734.
36. Dickson K, Katzman S, Delgado E, et al. 1994. Delayed unions and nonunions of open tibial fractures. Correlation with arteriography results. Clin Orthop Relat Res 302: 189-193.